Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bazan

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Science (New York, N.Y.)|November 10, 2007
DUBA: a deubiquitinase that regulates type I interferon productionNobuhiko Kayagaki, Qui Phung, Salina Chan, et al.
Cell|June 19, 2007
A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesisMaxence V Nachury, Alexander V Loktev, Qihong Zhang, et al.
Immunity|November 16, 2005
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokinesJochen Schmitz, Alexander Owyang, Elizabeth Oldham, et al.
Breast (Edinburgh, Scotland)|February 4, 2011
Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumourVeronique Lorgis, Marie Paule Algros, Cristian Villanueva, et al.
International Journal of Clinical Oncology|July 6, 2012
Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?Erion Dobi, Fernando Bazan, Armelle Dufresne, et al.
Nature|December 22, 2009
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survivalMartin Schwickart, Xiaodong Huang, Jennie R Lill, et al.
The Biochemical Journal|October 23, 2008
Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1)John W Blankenship, Eugene Varfolomeev, Tatiana Goncharov, et al.
Bulletin Du Cancer|August 6, 2014
[Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region]Virginie Nerich, Elsa Curtit, Fernando Bazan, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumabQuentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, et al.
Nature Structural & Molecular Biology|March 24, 2023
Mechanism of receptor assembly via the pleiotropic adipokine LeptinAlexandra Tsirigotaki, Ann Dansercoer, Koen H G Verschueren, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Science (New York, N.Y.)|November 10, 2007
DUBA: a deubiquitinase that regulates type I interferon productionNobuhiko Kayagaki, Qui Phung, Salina Chan, et al.
Cell|June 19, 2007
A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesisMaxence V Nachury, Alexander V Loktev, Qihong Zhang, et al.
Immunity|November 16, 2005
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokinesJochen Schmitz, Alexander Owyang, Elizabeth Oldham, et al.
Breast (Edinburgh, Scotland)|February 4, 2011
Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumourVeronique Lorgis, Marie Paule Algros, Cristian Villanueva, et al.
International Journal of Clinical Oncology|July 6, 2012
Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?Erion Dobi, Fernando Bazan, Armelle Dufresne, et al.
Nature|December 22, 2009
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survivalMartin Schwickart, Xiaodong Huang, Jennie R Lill, et al.
The Biochemical Journal|October 23, 2008
Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1)John W Blankenship, Eugene Varfolomeev, Tatiana Goncharov, et al.
Bulletin Du Cancer|August 6, 2014
[Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region]Virginie Nerich, Elsa Curtit, Fernando Bazan, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumabQuentin Jacquinot, Nathalie Meneveau, Antoine Falcoz, et al.
Nature Structural & Molecular Biology|March 24, 2023
Mechanism of receptor assembly via the pleiotropic adipokine LeptinAlexandra Tsirigotaki, Ann Dansercoer, Koen H G Verschueren, et al.
Pageof 11